Strategies to inhibit TGF-β signaling (SMADs and MRTFA) might limit the negative consequences of obesity by directly retaining the metabolic functions of adipocytes. The gene discussed is MRTFA; the disease is obesity due to melanocortin 4 receptor deficiency.